Eam Investors, LLC Adverum Biotechnologies, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$10.3 - $21.64 $1.34 Million - $2.81 Million	-129,799 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.53 - $25.64 $194,219 - $583,797	22,769 Added 21.27%	129,799 $2.71 Million
Q1 2020 May 13, 2020	BUY	$7.98 - $16.32 $854,099 - $1.75 Million	107,030 New	107,030 $1.05 Million
Q3 2019 Nov 13, 2019	SELL	$5.24 - $15.89 $1.22 Million - $3.69 Million	-232,043 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.1 - $11.89 $1.18 Million - $2.76 Million	232,043 New	232,043 $2.76 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $438M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.